Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Molecular Cytogenetics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

Published by IMARC Services Private Limited Product code 967676
Published Content info 142 Pages
Delivery time: 2-3 business days
Price
Back to Top
Molecular Cytogenetics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025
Published: October 16, 2020 Content info: 142 Pages
Description

The global molecular cytogenetics market grew at a CAGR of around 12% during 2014-2019. Molecular cytogenetics refers to the biomedical research of deoxyribonucleic acid (DNA) mechanisms to investigate genetic mutations and disorders. It studies the structural and functional organization of the chromosomes and their nucleus, genomic variations, expression, evolution and abnormalities, especially in medicinal and cancer-related genetics. Techniques such as DNA amplification, DNA isolation, gene screens, virtual karyotyping and fluorescence in situ hybridization (FISH) are commonly used for molecular cytogenetics by using DNA probes to visualize and label the genome or its targeted regions. These techniques are highly beneficial in the diagnosis and treatment of various malignant tumors and hematological malignancies.

The increasing prevalence of cancer and other genetic disorders, along with the rising geriatric population, is one of the key factors driving the growth of the market. Molecular cytogenetics is primarily being used for developing predictive models of disease traits and effective treatment strategies. Furthermore, the widespread adoption of targeted therapies for cancer treatment is also augmenting the market growth. FISH and Comparative Genomic Hybridization (CGH) are also used for pharmacogenomic biomarker studies to analyze cancer progression stages and provide personalized treatment to the patient. Additionally, various technological advancements, such as the development of improved consumables, reagents, software and kits, are acting as other growth-inducing factors. These advancements aid in generating duplicatable, accurate and reliable clinical-pathological test results. Other factors, including significant improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biomedical sciences, are anticipated to drive the market further. Looking forward, IMARC Group expects the global molecular cytogenetics market to continue its strong growth during the next five years.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global molecular cytogenetics market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, product type, technology, application and end user.

Breakup by Product Type:

  • Instruments
  • Consumables
  • Software and Services
  • Others

Breakup by Technology:

  • Comparative Genomic Hybridization
  • Fluorescence in SITU Hybridization (FISH)
  • Immunohistochemistry
  • Karyotyping
  • Others

Breakup by Application:

  • Genetic Disorders
  • Oncology
  • Personalized Medicine
  • Others

Breakup by End User:

  • Clinical and Research Laboratories
  • Hospitals and Pathology Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies Inc., Applied Spectral Imaging Inc., Biological Industries, Bio-RAD Laboratories Inc., BioView Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Illumina Inc., Oxford Gene Technology, Perkinelmer Inc. and Quest Diagnostics Incorporated.

Key Questions Answered in This Report:

  • How has the global molecular cytogenetics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global molecular cytogenetics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global molecular cytogenetics market and who are the key players?
  • What is the degree of competition in the industry?
Table of Contents
Product Code: SR1019N17_Report

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Molecular Cytogenetics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Comparative Genomic Hybridization
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Fluorescence in SITU Hybridization (FISH)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Immunohistochemistry
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Karyotyping
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Genetic Disorders
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oncology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Personalized Medicine
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Clinical and Research Laboratories
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals and Pathology Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Agilent Technologies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Applied Spectral Imaging Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Biological Industries
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Bio-RAD Laboratories Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 BioView Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Danaher Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 F. Hoffmann-La Roche AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 SWOT Analysis
    • 15.3.9 Illumina Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Oxford Gene Technology
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Perkinelmer Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Quest Diagnostics Incorporated
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials

List of Figures

  • Figure 1: Global: Molecular Cytogenetics Market: Major Drivers and Challenges
  • Figure 2: Global: Molecular Cytogenetics Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Molecular Cytogenetics Market: Breakup by Product Type (in %), 2019
  • Figure 4: Global: Molecular Cytogenetics Market: Breakup by Technology (in %), 2019
  • Figure 5: Global: Molecular Cytogenetics Market: Breakup by Application (in %), 2019
  • Figure 6: Global: Molecular Cytogenetics Market: Breakup by End User (in %), 2019
  • Figure 7: Global: Molecular Cytogenetics Market: Breakup by Region (in %), 2019
  • Figure 8: Global: Molecular Cytogenetics Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 9: Global: Molecular Cytogenetics (Instruments) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 10: Global: Molecular Cytogenetics (Instruments) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 11: Global: Molecular Cytogenetics (Consumables) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 12: Global: Molecular Cytogenetics (Consumables) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 13: Global: Molecular Cytogenetics (Software and Services) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 14: Global: Molecular Cytogenetics (Software and Services) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 15: Global: Molecular Cytogenetics (Other Product Types) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 16: Global: Molecular Cytogenetics (Other Product Types) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 17: Global: Molecular Cytogenetics (Comparative Genomic Hybridization) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 18: Global: Molecular Cytogenetics (Comparative Genomic Hybridization) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 19: Global: Molecular Cytogenetics (Fluorescence in SITU Hybridization - FISH) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 20: Global: Molecular Cytogenetics (Fluorescence in SITU Hybridization - FISH) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 21: Global: Molecular Cytogenetics (Immunohistochemistry) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 22: Global: Molecular Cytogenetics (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 23: Global: Molecular Cytogenetics (Karyotyping) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 24: Global: Molecular Cytogenetics (Karyotyping) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 25: Global: Molecular Cytogenetics (Other Technologies) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 26: Global: Molecular Cytogenetics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 27: Global: Molecular Cytogenetics (Genetic Disorders) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 28: Global: Molecular Cytogenetics (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 29: Global: Molecular Cytogenetics (Oncology) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 30: Global: Molecular Cytogenetics (Oncology) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 31: Global: Molecular Cytogenetics (Personalized Medicine) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 32: Global: Molecular Cytogenetics (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 33: Global: Molecular Cytogenetics (Other Applications) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 34: Global: Molecular Cytogenetics (Other Applications) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 35: Global: Molecular Cytogenetics (Clinical and Research Laboratories) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 36: Global: Molecular Cytogenetics (Clinical and Research Laboratories) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 37: Global: Molecular Cytogenetics (Hospitals and Pathology Laboratories) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 38: Global: Molecular Cytogenetics (Hospitals and Pathology Laboratories) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 39: Global: Molecular Cytogenetics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 40: Global: Molecular Cytogenetics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 41: Global: Molecular Cytogenetics (Other End Users) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 42: Global: Molecular Cytogenetics (Other End Users) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 43: North America: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 44: North America: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 45: United States: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 46: United States: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 47: Canada: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 48: Canada: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 49: Asia Pacific: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 50: Asia Pacific: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 51: China: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 52: China: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 53: Japan: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 54: Japan: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 55: India: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 56: India: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 57: South Korea: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 58: South Korea: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 59: Australia: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 60: Australia: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 61: Indonesia: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 62: Indonesia: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 63: Others: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 64: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 65: Europe: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 66: Europe: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 67: Germany: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 68: Germany: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 69: France: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 70: France: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 71: United Kingdom: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 72: United Kingdom: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 73: Italy: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 74: Italy: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 75: Spain: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 76: Spain: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 77: Russia: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 78: Russia: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 79: Others: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 80: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 81: Latin America: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 82: Latin America: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 83: Brazil: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 84: Brazil: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 85: Mexico: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 86: Mexico: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 87: Others: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 88: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 89: Middle East and Africa: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 90: Middle East and Africa: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 91: Global: Molecular Cytogenetics Industry: SWOT Analysis
  • Figure 92: Global: Molecular Cytogenetics Industry: Value Chain Analysis
  • Figure 93: Global: Molecular Cytogenetics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Molecular Cytogenetics Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Molecular Cytogenetics Market Forecast: Breakup by Type (in Million US$), 2020-2025
  • Table 3: Global: Molecular Cytogenetics Market Forecast: Breakup by Technology (in Million US$), 2020-2025
  • Table 4: Global: Molecular Cytogenetics Market Forecast: Breakup by Application (in Million US$), 2020-2025
  • Table 5: Global: Molecular Cytogenetics Market Forecast: Breakup by End User (in Million US$), 2020-2025
  • Table 6: Global: Molecular Cytogenetics Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 7: Global: Molecular Cytogenetics Market Structure
  • Table 8: Global: Molecular Cytogenetics Market: Key Players
Back to Top